Prevalence of inflammatory bowel disease related dysplasia and cancer in 1500 colonoscopies from a referral center in northwestern Greece

Journal of Crohn's and Colitis

Volumn 5, Issue 1, 2011, Pages 19-23

  Katsanos, Konstantinos H ^a   Stamou, Paraskevi ^a   Tatsioni, Athina ^a   Tsianos, Vasileios E ^a   Zoumbas, Stefanos ^a   Kavvadia, Spyridoula ^a   Giga, Anna ^a   Vagias, Ioannis ^a   Christodoulou, Dimitrios K ^a   Tsianos, Epameinondas V ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Cancer; Crohn's disease; Dysplasia; Follow up; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MESALAZINE;

ADULT; ARTICLE; COLITIS; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; GREECE; HUMAN; ILEITIS; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE CANCER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROCTITIS; REMISSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; COLONOSCOPY; CROHN DISEASE; GREECE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 78951469508     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.09.001     Document Type: Article

References (44)

1. Ekbom A., Helmick C., Zack M., Adam H.-O. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990, 11:357-359.
2. Denroede G.J., Taylor W.F., Sauer W.G., Jackman R.J., Stickler G.B. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971, 285:17-21.
3. Bargen J.A. Chronic ulcerative colitis associated with malignant disease. Arch Surg 1928, 17:561-576.
4. Summers R.W. Is the risk of cancer in ulcerative colitis increasing. Am J Gastroenterol 1995, 90:337.
5. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001 Apr, 48(4):526-535.
6. Travis S.P.L. Insurance risks for patients with ulcerative colitis or Crohn's disease. Alim Pharmacol Ther 1997, 11:51-59.
7. Palli D., Trallori G., Saieva C., Tarantino O., Edili E., D'Albasio G., et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study. Gut 1998, 42:175-179.
8. Hordijk M.L., Shivananda S. Risk of cancer in inflammatory bowel disease. Why are the results in the reviewed literature so varied. Scand J Gastroenterol 1989, 24:70-74.
9. Wolters F.L., Russel M.G., Sijbrandij J., Ambergen T., Odes S., Riis L., et al. On behalf of the European Collaborative Study Group on Inflammatory Bowel D: phenotype at diagnosis predicts recurrence rates in crohn's disease. Gut 2006, 55:1124-1130.
10. Tsianos E.V., Katsanos K.H., Christodoulou D., Dimoliatis I., Kogevinas A. Northwest Greece Inflammatory Bowel Disease Study Group. Continuing low incidence of Crohn's disease in Northwest Greece. Dig Liver Dis 2003, 35:99-103.
11. Christodoulou D.K., Katsanos K.H., Kitsanou M., Stergiopoulou C., Hatzis J., Tsianos E.V. Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis 2002, 34:781-786.
12. Tsianos E.V., Merkouropoulos M., Massalas K., Dalekos G., Logan R.F. Incidence of inflammatory bowel disease in Northwest Greece; rarity of Crohn's disease in an area where ulcerative colitis is common. Gut 1994, 35:369-372.
13. Christodoulou D., Skopelitou A.S., Katsanos K.H., Katsios C., Agnantis N., Price A., et al. Small bowel adenocarcinoma presenting as a first manifestation of Crohn's disease; report of a case and literature review. Eur J Gastroenterol Hepatol 2002, 14:805-810.
14. Viscido A., Bagnardi V., Sturniolo G.C., Annese V., Frieri G., D'Arienzo A., et al. Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study. Dig Liver Dis 2001, 33:686-692.
15. Blomqvist P., Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997, 32:1134-1139.
16. Tsianos E.V. Risk of cancer in inflammatory bowel disease. Eur J Int Med 2000, 11:75-78.
17. Jones J.H. Colonic cancer and Crohn's disease. Gut 1969, 10:651-654.
18. Greenstein A.J., Gennuso R., Sachar D.B., Heimann T., Smith H., Janowitz H.D., et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985, 56:2914-2921.
19. Solomon M.J., Schnitzler M. Cancer and inflammatory bowel disease. Bias, epidemiology, surveillance, and treatment. World J Surg 1998, 22:352-358.
20. Bansal P., Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 1996, 91:44-48.
21. Langholz E., Munkholm P., Krasilnikoff P.A., Binder V. Inflammatory bowel diseases with onset in childhood. Scand J Gastroenterol 1977, 32:139-147.
22. Lashner B.A. Risk factors for small bowel cancer in Crohn's disease. Dig Dis Sci 1992, 37:1179-1184.
23. Ky A., Sohn N., Weinstein M.A., Korelitz B.I. Carcinoma arising in anorectal fistulas of Crohn' disease. Dis Colon Rect 1998, 41:992-996.
24. Munkholm P., Langholz E., Davidsen M., Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993, 105:1716-1723.
25. Lindgren A., Wallerstedt S., Olson R. Prevalence of Crohn's disease and simultaneous occurence of extraintestinal complications and cancer. Scand J Gastroenterol 1996, 31:74-78.
26. Langholz E., Munkholm P., Krasilnikoff P.A., Binder V. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity and mortality in a regional cohort. Scand J Gastroenterol 1997, 32:139-147.
27. Gyde S.N., Prior P., Macartney J.C., Thompson H., Waterhouse J.A.H., Allan R.N. Malignancy in Crohn's disease. Gut 1980, 21:1024-1029.
28. Tsianos E.V. The risk of cancer in inflammatory bowel disease. Eur J Int Med 2000, 11:75-78.
29. Katsanos K.H., Christodoulou D.K., Zioga A., Tsianos E.V. Cutaneous nevi pigmentosus during infliximab therapy in a patient with Crohn's disease: fallacy or coincidence?. Inflamm Bowel Dis 2003, 9:279.
30. Greenstein A.J. Cancer in inflammatory bowel disease. Mt Sinai J Med 2000, 67:227-240.
31. Itzkowitz S.H. Cancer prevention in patients with inflammatory bowel disease. Gastroenterol Clin North Am 2002, 31:1133-1144.
32. Moody G.A., Jayanthi V., Probert C.S.J., Mac Kay H., Mayberry J.F. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 1996, 8:1179-1183.
33. Christodoulou D.K., Katsanos K.H., Baltayannis G., Tzabouras N., Tsianos E.V. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in Northwest Greece. Hepatogastroenterology 2003, 50:1021-1024.
34. van der Eijk I., Stockbrugger R.W., Russel M.G. Influence of quality of care on quality of life in inflammatory bowel disease:literature review and studies planned. Eur J Int Med 2000, 11:228-234.
35. Biasco G., Rossini F.P., Hakim R., Brandi G., Di Battista M., Di Febo G., et al. Cancer surveillance in ulcerative colitis: critical analysis of long term prospective programme. Dig liver Dis 2002, 34:339-342.
36. Moum B. Medical treatment:does it influence the natural course of inflammatory bowel disease?. Eur J Int Med 2000, 11:197-203.
37. Eaden J.A., Mayberry J.F. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002, 51:V10-V12.
38. Sharan R., Schoen R.E. Cancer in inflammatory bowel disease. An evidence-based analysis and guide for physicians and patients. Gastroenterol Cin North Am 2002, 31:237-254.
39. Kornfeld D., Ekbom A., Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997, 41:522-525.
40. Nuako K.W., Ahlquist D.A., Mahoney D.W., Schaid D.J., Siems D.M., Lindor N.M. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1998, 115:1079-1083.
41. Askling J., Dickman P.W., Karlén P., Broström O., Lapidus A., Löfberg R., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001, 120:1356-1362.
42. Rhodes J.M. Surveillance for colitis-associated cancer: we cannot stop now. Dig Liver Dis 2002, 34:319-321.
43. Karlen P., Kornfeld D., Brostrom O., Lofberg R., Persson P.-G., Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998, 42:711-714.
44. Skopelitou A., Katsanos K.H., Michail M., Mitselou A., Tsianos E.V. Immunohistochemical expression of FHIT gene product in inflammatory bowel disease;significance and correlation with clinicopathological data. Eur J Gastroenterol Hepatol 2003, 665-673.